
浏览全部资源
扫码关注微信
1.400010 重庆,重庆医科大学附属第二医院肝胆外科
2.400016 重庆,重庆医科大学附属第一医院:肝胆外科
3.400016 重庆,重庆医科大学附属第一医院:急诊&重症医学科
[ 钮柏琳,E-mail:nberlin@126.com NIU Bailin, E-mail: nberlin@126.com
收稿:2018-10-20,
修回:2019-01-08,
纸质出版:2019-04-15
移动端阅览
成名翔, 李金政, 陈勇, 等. VEGF-C抑制Kupffer细胞激活减轻大鼠肝移植缺血再灌注损伤[J]. 第三军医大学学报, 2019,41(7):653-658.
Mingxiang CHENG, Jinzheng LI, Yong CHEN, et al. VEGF-C inhibits Kupffer cells activation and alleviates ischemia-reperfusion injury in rats after liver transplantation[J]. Journal of Third Military Medical University, 2019, 41(7): 653-658.
成名翔, 李金政, 陈勇, 等. VEGF-C抑制Kupffer细胞激活减轻大鼠肝移植缺血再灌注损伤[J]. 第三军医大学学报, 2019,41(7):653-658. DOI: 10.16016/j.1000-5404.201810125.
Mingxiang CHENG, Jinzheng LI, Yong CHEN, et al. VEGF-C inhibits Kupffer cells activation and alleviates ischemia-reperfusion injury in rats after liver transplantation[J]. Journal of Third Military Medical University, 2019, 41(7): 653-658. DOI: 10.16016/j.1000-5404.201810125.
目的
2
阐明血管内皮生长因子受体-3(vascular endothelial growth factor receptor-3
VEGFR-3) /血管内皮生长因子-c (vascular endothelial growth factor-c
VEGF-C)信号能否抑制Kupffer细胞(KCs)活化并减轻移植肝脏缺血再灌注损伤(ischemia reperfusion injury
IRI)。
方法
2
建立Lewis-Lewis大鼠肝移植模型,分为VEGF-C组(6对,在冷保存期经门静脉灌注VEGF-C)、对照组(6对,灌注等体积UW液)、假手术组(6只)。术后24 h处死动物,检测血清中丙氨酸氨基转移酶(ALT)、总胆红素(TBIL)、炎症因子水平,并进行病理学分析。分离KCs,RT-PCR检测VEGFR-3及极化特异性标记基因水平,EMSA检测NF-κB转录活性,Western blot检测细胞因子信号传导抑制因子1 (suppressor of cytokine signaling 1
SOCS1)和磷酸化糖原合成酶激酶3β(phosphorylated glycogen synthase kinase 3β
p-GSK3β)的表达。
结果
2
VEGF-C组中ALT和TBIL水平、肝脏损伤程度、促炎因子水平均较对照组降低(
P
<
0.05),而IL-10含量增加(
P
<
0.05)。VEGF-C组和对照组KCs中VEGFR-3的mRNA水平明显高于假手术组(
P
<
0.05)。VEGF-C组KCs中M1型基因表达、NF-κB活性较对照组明显降低(
P
<
0.05),而M2型基因水平及SOCS1/p-GSK3β的表达明显增高(
P
<
0.05)。
结论
2
VEGF-C通过抑制炎症反应和调节KCs极化从而减轻移植肝脏IRI。
Objective
2
To investigate whether vascular endothelial growth factor receptor-3 (VEGFR-3)/VEGF-C signaling suppresses activation of Kupffer cells (KCs) and attenuates hepatic ischemia-reperfusion injury (IRI) after liver transplantation.
Methods
2
Liver transplantation model was established in 12 pairs of Lewis-Lewis rats
6 pairs for VEGF-C group and the other for control group. The donor livers of the VEGF-C group were perfused with VEGF-C injection
via
portal vein during cold preservation
while those of control group were perfused with UW solution. Another 6 rats served as sham operation group. In 24 h after transplantation
all rats were sacrificed
and serum levels of alanine transaminase (ALT)
total bili
rubin (TBIL) and inflammatory cytokines
as well as histological changes were detected and observed. KCs were isolated from the grafts. RT-PCR was used to evaluate the expression of VEGFR-3 and polarization-specific marker genes
EMSA was utilized to quantify the nuclear factor-κB (NF-κB) transcriptional activity
and Western blotting was employed to assess the expression of suppressor of cytokine signaling 1(SOCS1) and phosphorylated glycogen synthase kinase 3β (p-GSK3β).
Results
2
Compared with the controls
VEGF-C perfusion reduced serum ALT and TBIL levels
alleviated liver damage and suppressed the contents of proinflammatory cytokines (
P
<
0.05)
but increased IL-10 level (
P
<
0.05). The VEGFR-3 mRNA level in KCs was increased after reperfusion in both VEGF-C group and control group (
P
<
0.05) when compared with the sham operation group (
P
<
0.05). In KCs
the mRNA levels of M1 specific marker genes and NF-κB activity were significantly inhibited in VEGF-C group (
P
<
0.05)
while the mRNA levels of M2 specific marker genes and the expression of SOCS1 and p-GSK3β were enhanced when compared with control group (
P
<
0.05).
Conclusion
2
Exogenous VEGF-C protects liver graft from IRI by regulating the inflammatory responses and modifying polarization of KCs.
ZHANG X J, CHENG X, YAN Z Z, et al. An ALOX12-12-HETE-GPR31 signaling axis is a key mediator of hepatic ischemia-reperfusion injury[J]. Nat Med, 2017, 24(1): 73-83. DOI:10.1038/nm.4451.
LU L, ZHOU H M, NI M, et al. Innate immune regulations and liver ischemia-reperfusion injury[J]. Transplantation, 2016, 100(12): 2601-2610. DOI:10.1097/TP.0000000000001411.
TOMIYAMA K, IKEDA A, UEKI S, et al. Inhibition of Kupffer cell-mediated early proinflammatory response with carbon monoxide in transplant-induced hepatic ischemia/reperfusion injury in rats[J]. Hepatology, 2008, 48(5): 1608-1620. DOI:10.1002/hep.22482.
LI X F, WU Y K, ZHANG W F, et al. Pre-conditioning with tanshinone ⅡA attenuates the ischemia/reperfusion injury caused by liver grafts via regulation of HMGB1 in rat Kupffer cells[J]. Biomed Pharmacother, 2017, 89: 1392-1400. DOI:10.1016/j.biopha.2017.03.022.
彭勇, 龚建平, 刘长安, 等.甘氨酸对大鼠肝移植缺血再灌注损伤库普弗细胞CD14和核因子-κB的影响[J].中华肝脏病杂志, 2005, 13(3) : 179-182.
PENG Y, GONG J P, LIU C A, et al. The effect of glycine on CD14 and NF-kappa B in Kupffer cells from rat liver grafts after ischemia-reperfusion injury[J]. Chin J Hepatol, 2005, 13(3): 179-182.
MURRAY P J. Macrophage polarization[J]. Annu Rev Physiol, 2017, 79(1): 541-566. DOI:10.1146/annurev-physiol-022516-034339.
ZHANG Y B, LU Y, MA L, et al. Activation of vascular endothelial growth factor receptor-3 in macrophages restrains TLR4-NF-κb signaling and protects against endotoxin shock[J]. Immunity, 2014, 40(4): 501-514. DOI:10.1016/j.immuni.2014.01.013.
ZHAI Y, QIAO B, SHEN X D, et al. Evidence for the pivotal role of endogenous Toll-like receptor 4 ligands in liver ischemia and reperfusion injury[J]. Transplantation, 2008, 85(7): 1016-1022. DOI:10.1097/TP.0b013e3181684248.
KAMADA N, CALNE R Y. A surgical experience with five hundred thirty liver transplants in the rat[J]. Surgery, 1983, 93(1 Pt 1): 64-69.
XIAO Z Y, BANAN B, JIA J L, et al. CD47 blockade reduces ischemia/reperfusion injury and improves survival in a rat liver transplantation model[J]. Liver Transpl, 2015, 21(4): 468-477. DOI:10.1002/lt.24059.
SUZUKI S, TOLEDO-PEREYRA L H, RODRIGUEZ F J, et al. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine[J]. Transplantation, 1993, 55(6): 1265-1272.
ZENG W Q, ZHANG J Q, LI Y, et al. A new method to isolate and culture rat kupffer cells[J]. PLoS ONE, 2013, 8(8): e70832. DOI:10.1371/journal.pone.0070832.
MARTIN M, REHANI K, JOPE R S, et al. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3[J]. Nat Immunol, 2005, 6(8): 777-784. DOI:10.1038/ni1221.
YU J L, ZHANG X F, KUZONTKOSKI P M, et al. Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway[J]. Cell Commun Signal, 2014, 12: 25. DOI:10.1186/1478-811X-12-25.
ENGELMANN D, MAYOLI-NüSSLE D, MAYRHOFER C, et al. E2F1 promotes angiogenesis through the VEGF-C/VEGFR-3 axis in a feedback loop for cooperative induction of PDGF-B[J]. J Mol Cell Biol, 2013, 5(6): 391-403. DOI:10.1093/jmcb/mjt035.
BALA S S, MARCOS M, KODYS K, et al. Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor {alpha} (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease[J ] . J Biol Chem, 2011, 286(2): 1436-1444. DOI:10.1074/jbc.M110.145870.
DONG Z J, WEI H M, SUN R, et al. The roles of innate immune cells in liver injury and regeneration[J]. Cell Mol Immunol, 2007, 4(4): 241-252.
LI Y K, MA D X, WANG Z M, et al. MicroRNA-155 deficiency in kupffer cells ameliorates liver ischemia-reperfusion injury in mice[J]. Transplantation, 2017, 101(7): 1600-1608. DOI:10.1097/TP.0000000000001765.
RAPTIS D A, LIMANI P, JANG J H, et al. GPR120 on Kupffer cells mediates hepatoprotective effects of ω3-fatty acids[J]. J Hepatol, 2014, 60(3): 625-632. DOI:10.1016/j.jhep.2013.11.006.
MANSELL A, SMITH R, DOYLE S L, et al. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation[J]. Nat Immunol, 2006, 7(2): 148-155. DOI:10.1038/ni1299.
REN F, DUAN Z P, CHENG Q, et al. Inhibition of glycogen synthase kinase 3 beta ameliorates liver ischemia reperfusion injury by way of an interleukin-10-mediated immune regulatory mechanism[J]. Hepatology, 2011, 54(2): 687-696. DOI:10.1002/hep.24419.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621